NSE BSE
transgene biotek ltd. stock

TRANSGENE BIOTEK LTD. Share Price

- - (%)
- NSE: TRABI

TRANSGENE BIOTEK LTD. Share Price Update

As of the latest trading session, TRANSGENE BIOTEK LTD. share price is currently at 10.39, which is up by 0.23 from its previous closing. Today, the stock has fluctuated between 9.90 and 10.66. Over the past year, TRANSGENE BIOTEK LTD. has achieved a return of 151.48 %. In the last month alone, the return has been 36.92 %. Read More...

TRANSGENE BIOTEK LTD. Performance

Day Range

Low9.90 High10.66
10.39

52 Week Range

Low 3.62 High 12.46
10.39

TRANSGENE BIOTEK LTD. Share Price

526139

TRABI

img img img img
No Data Available

Open Price

10.00

Prev. Close

10.16

Volume (Shares)

181069.00

Total traded value

18.81

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

TRANSGENE BIOTEK LTD. Fundamentals


(Standalone)

Market Cap (Cr) 78.72
PE Ratio (TTM) 0.00
Book Value / Share -0.90
Beta 0.29
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.27

TRANSGENE BIOTEK LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 0.05
Operating Expense 0.37
Net Profit -0.27
Net Profit Margin (%) -540.00
Earnings Per Share (EPS) -0.04
EBITDA -0.22
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.05
Operating Expense 0.21
Net Profit -0.12
Net Profit Margin (%) -240.00
Earnings Per Share (EPS) -0.02
EBITDA -0.06
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 0.05
Operating Expense 0.22
Net Profit -0.13
Net Profit Margin (%) -260.00
Earnings Per Share (EPS) -0.02
EBITDA -0.08
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 0.10
Operating Expense 0.27
Net Profit -0.13
Net Profit Margin (%) -130.00
Earnings Per Share (EPS) -0.17
EBITDA -0.08
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 1.52
Net Profit -1.47
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.19
EBITDA -0.17
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.23
Operating Expense 1.06
Net Profit -0.66
Net Profit Margin (%) -286.95
Earnings Per Share (EPS) -0.09
EBITDA -0.44
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.06
Operating Expense 6.23
Net Profit -6.01
Net Profit Margin (%) -10016.66
Earnings Per Share (EPS) -0.79
EBITDA -0.87
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.09
Operating Expense 10.70
Net Profit -10.40
Net Profit Margin (%) -11555.55
Earnings Per Share (EPS) -1.37
EBITDA -0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.17
Operating Expense 10.87
Net Profit -10.43
Net Profit Margin (%) -6135.29
Earnings Per Share (EPS) -1.38
EBITDA -0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 11.14
Net Profit -10.96
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.45
EBITDA -0.67
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.50
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.87
EBITDA Margin -733.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2.29
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.59
EBITDA Margin -277.78
Particulars MAR 2021 (Values in Cr)
Book Value / Share 2.94
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin -152.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 4.31
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.26
EBITDA Margin 0.00
Particulars MAR 2019 (Values in Cr)
Book Value / Share 5.76
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.20
EBITDA Margin -591.17
Particulars MAR 2023 (Values in Cr)
Book Value / Share -0.82
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -733.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share -0.03
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 5.23
EBITDA Margin -277.78
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.62
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.10
EBITDA Margin -152.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 1.99
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.47
EBITDA Margin 0.00
Particulars MAR 2019 (Values in Cr)
Book Value / Share 3.44
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.31
EBITDA Margin -585.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 142.35
Total Liabilities 142.35
Total Equity 11.36
Share Outstanding 75770001
Price to Book Ratio -3.04
Return on Assets (%) -4.22
Return on Capital (%) -24.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 147.10
Total Liabilities 147.10
Total Equity 17.37
Share Outstanding 75770001
Price to Book Ratio -120.33
Return on Assets (%) -7.07
Return on Capital (%) -35.4
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 156.88
Total Liabilities 156.88
Total Equity 22.23
Share Outstanding 75770001
Price to Book Ratio 7.39
Return on Assets (%) -6.65
Return on Capital (%) -31.08
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 166.75
Total Liabilities 166.75
Total Equity 32.67
Share Outstanding 75770000
Price to Book Ratio 1.51
Return on Assets (%) -6.57
Return on Capital (%) -25.49
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 176.54
Total Liabilities 176.54
Total Equity 43.63
Share Outstanding 75770000
Price to Book Ratio 1.16
Return on Assets (%) -4.98
Return on Capital (%) -16.66
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 32.47
Total Liabilities 32.47
Total Equity -6.20
Share Outstanding 75770000
Price to Book Ratio -3.04
Return on Assets (%) -18.49
Return on Capital (%) -86.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 37.21
Total Liabilities 37.21
Total Equity -0.19
Share Outstanding 75770000
Price to Book Ratio -120.33
Return on Assets (%) -27.94
Return on Capital (%) -88.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 46.99
Total Liabilities 46.99
Total Equity 4.66
Share Outstanding 75770000
Price to Book Ratio 7.39
Return on Assets (%) -22.20
Return on Capital (%) -65.23
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 56.86
Total Liabilities 56.86
Total Equity 15.09
Share Outstanding 75770000
Price to Book Ratio 1.51
Return on Assets (%) -19.27
Return on Capital (%) -43.12
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 66.65
Total Liabilities 66.65
Total Equity 26.05
Share Outstanding 75770000
Price to Book Ratio 1.16
Return on Assets (%) -13.19
Return on Capital (%) -24.99
Particulars MAR 2023 (Values in Cr)
Net Income -6.00
Cash from Operations 0.00
Cash from Investing -0.01
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income -10.40
Cash from Operations 0.09
Cash from Investing -0.09
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.09
Particulars MAR 2021 (Values in Cr)
Net Income -10.43
Cash from Operations 0.01
Cash from Investing -0.02
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow 0.03
Particulars MAR 2020 (Values in Cr)
Net Income -10.96
Cash from Operations 0.13
Cash from Investing 0.00
Cash from Financing -0.20
Net change in Cash -0.06
Free Cash Flow 0.13
Particulars MAR 2019 (Values in Cr)
Net Income -8.79
Cash from Operations -1.73
Cash from Investing 1.73
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow -1.66
Particulars MAR 2023 (Values in Cr)
Net Income -6.00
Cash from Operations 0.00
Cash from Investing -0.01
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income -10.40
Cash from Operations 0.09
Cash from Investing -0.09
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.09
Particulars MAR 2021 (Values in Cr)
Net Income -10.43
Cash from Operations 0.01
Cash from Investing -0.03
Cash from Financing 0.00
Net change in Cash -0.02
Free Cash Flow 0.03
Particulars MAR 2020 (Values in Cr)
Net Income -10.96
Cash from Operations 0.13
Cash from Investing 0.00
Cash from Financing -0.20
Net change in Cash -0.06
Free Cash Flow 0.13
Particulars MAR 2019 (Values in Cr)
Net Income -8.79
Cash from Operations -1.73
Cash from Investing 1.73
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow -1.66
Company Name Price P/E P/B Market Cap 52 Week Low/High
TRANSGENE BIOTEK LTD. 10.16 0.00 7.18 76.98 3.62 / 12.46
APOLLO HOSPITALS ENTER. L 6392.30 102.42 13.26 91911.47 4727.00 / 6871.30
FORTIS MALAR HOSPITALS LIMITED 62.50 0.00 1.07 117.14 44.00 / 107.94
SHREE PACETRONIX LTD. 190.50 20.42 5.26 68.57 138.00 / 391.90
VIMTA LABS LIMITED 516.55 28.20 3.58 1145.22 390.60 / 621.40
Company Name Price P/E P/B Market Cap 52 Week Low/High

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 9.50
  • 26 Days 8.50
  • 10 Days 9.30
  • 50 Days 8.00
  • 12 Days 9.20
  • 100 Days 8.40
  • 20 Days 9.00
  • 200 Days 5.00
10.03
PIVOT
First Resistance 10.29
Second Resistance 10.42
Third Resistance 10.68
First Support 9.90
Second Support 9.64
Third Support 9.51
RSI 79.55
MACD 0.74
Commodity Channel Index (CCI) 360.24
ADX 68.16
Williams % R 0.00

Over 1 Month

down

36.92

Over 3 Months

down

32.29

Over 6 Months

down

16.51

Over 1 Year

down

151.48

Over 3 Years

down

31.28

Over 5 Years

down

26.39

TRANSGENE BIOTEK LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

TRANSGENE BIOTEK LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
76.36
Promoter Holdings
23.63
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Dr K Koteswara Rao Shareholding of Promoter and Promoter Group 1.5211902E7 21.89
Kollipara Nirmala Shareholding of Promoter and Promoter Group 1192000.0 1.72
Kollipara Srinivas Shareholding of Promoter and Promoter Group 24000.0 0.03

TRANSGENE BIOTEK LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About TRANSGENE BIOTEK LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by TRANSGENE BIOTEK LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Transgene Biotek Ltd?

Answer Field

The share price of Transgene Biotek Ltd for NSE is ₹ 0.00 and for BSE is ₹ 10.39.

What is the Market Cap of Transgene Biotek Ltd?

Answer Field

The market cap of Transgene Biotek Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 78.70 Cr. as of now.

What is the 52 Week High and Low of Transgene Biotek Ltd?

Answer Field

The 52 Week High and Low of Transgene Biotek Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 12.46 and ₹ 3.62.

How to Buy Transgene Biotek Ltd share?

Answer Field

You can trade in Transgene Biotek Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Transgene Biotek Ltd?

Answer Field

The 1 year returns on the stock has been 151.48%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader